Global Neonate Bilirubin Phototherapy Equipment Market Research Report 2023

Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.

According to Researcher's new survey, global Neonate Bilirubin Phototherapy Equipment market is projected to reach US$ 294.2 million in 2029, increasing from US$ 243 million in 2022, with the CAGR of 2.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neonate Bilirubin Phototherapy Equipment market research.

The market driver for Neonate Bilirubin Phototherapy Equipment is the increasing prevalence of neonatal jaundice and the growing awareness of the importance of early and effective treatment to manage this condition. Neonate Bilirubin Phototherapy Equipment is specialized medical equipment used to treat neonatal jaundice, a common condition in newborn babies caused by the accumulation of bilirubin in the blood. Several factors contribute to the growing demand for Neonate Bilirubin Phototherapy Equipment in the market:

Prevalence of Neonatal Jaundice: Neonatal jaundice is one of the most common medical conditions in newborns, affecting a significant number of infants worldwide.

Impact on Neonatal Health: Untreated or poorly managed neonatal jaundice can lead to serious complications, including kernicterus and neurological damage. Phototherapy is an effective treatment to prevent these complications.

Non-Invasive Treatment: Bilirubin phototherapy is a non-invasive treatment that reduces the need for more invasive procedures, such as blood transfusions, in neonates with jaundice.

Medical Advancements and Technology: Advances in medical technology and phototherapy equipment design have improved the efficiency and effectiveness of neonate bilirubin phototherapy.

Rising Awareness: Increased awareness among healthcare providers and parents about the importance of early diagnosis and treatment of neonatal jaundice drives the demand for phototherapy equipment.

Improved Neonatal Care Facilities: Expanding neonatal care facilities, particularly in developing regions, create a higher demand for neonate bilirubin phototherapy equipment.

Government Initiatives: Government initiatives and healthcare programs focusing on newborn health and well-being contribute to the adoption of neonate bilirubin phototherapy equipment.

Technological Advancements: Ongoing advancements in phototherapy technology, such as the development of LED-based phototherapy devices, drive the adoption of newer and more efficient equipment.

Hospital and NICU Investments: Hospitals and neonatal intensive care units (NICUs) invest in advanced neonate bilirubin phototherapy equipment to enhance the quality of neonatal care.

Growing Preterm Births: Preterm infants are more susceptible to neonatal jaundice, leading to an increased demand for neonate bilirubin phototherapy equipment.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neonate Bilirubin Phototherapy Equipment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GE Healthcare

Weyer GmbH

Delta Medical International

Natus Medical Incorporated

Medicor

Drager

Zeal Medical

MTTS

David Medical Device

BEING MEDICAL DEVICE

BIOBASE

Julongsanyou Technology

Phoenix Medical Systems

Ibis Medical

Apothecaries Sundries Manufacturing



Segment by Type


Contact Type

Contactless Type



Segment by Application


Hospitals

Confinement Centers

Others


Consumption by Region


North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

The Neonate Bilirubin Phototherapy Equipment report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Manufacturers’ Competition Patterns

Chapter 3: Country Level Sales Analysis

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6: Manufacturers’ Outline

Chapter 7: Industry Chain, Market Channel and Customer Analysis

Chapter 8: Market Opportunities and Challenges

Chapter 9: Market Conclusions

Chapter 10: Research Methodology and Data Source